Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,269,432
+$32,157 QoQ
Shares Held
8,100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#557
of 1,603 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Allianz Asset Management GmbH holds $5,256,144,156 across 13 Drug Manufacturers - General names. NVS ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
6,830,190 | $1,295,140,626 | |
| 2 | JNJ |
Johnson & Johnson
|
4,873,739 | $1,237,783,491 | |
| 3 | LLY |
ELI LILLY & Co
|
477,197 | $572,364,441 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,713,343 | $477,164,575 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,275,402 | $476,828,662 | |
| 6 | ABBV |
AbbVie Inc.
|
1,566,077 | $394,087,615 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,853,184 | $360,471,266 | |
| 8 | AMGN |
Amgen Inc
|
636,542 | $230,504,586 |
All Filings in NVS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,269,432 | 8,100 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,237,275 | 8,100 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $716,924 | 5,200 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $551,432 | 4,300 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $762,363 | 6,300 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $746,916 | 6,700 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $544,936 | 5,600 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $897,156 | 7,800 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $830,388 | 7,800 | Shares | Defined | 2024-08-13 | |
| 2022-06-30 | $3,915,091 | 46,316 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,538,862 | 120,101 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $10,588,330 | 121,051 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $9,974,379 | 121,966 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $10,160,121 | 111,356 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $9,742,241 | 113,971 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $11,658,894 | 123,466 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $13,425,232 | 154,384 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $13,481,365 | 154,355 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $13,866,853 | 168,185 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||